Skip to main content
. Author manuscript; available in PMC: 2017 Oct 25.
Published in final edited form as: Clin Breast Cancer. 2012 Apr;12(2):81–86. doi: 10.1016/j.clbc.2012.01.001

Table 6.

Subset Analysis of Patients According to Their Prior Exposure to Trastuzumab and Outcomes

Parameter Prior Trastuzumab No Trastuzumab
No. of patients 26 20
Median OS 26.6 mo 37.8 mo
1-y survival 92.3% (95% CI, 82.6%-100%) 90.0% (95% CI, 77.8%-100%)
Median TTP 8.6 mo 17.0 mo
No. (%) of responders 16 (61.5%) 15 (75%)

Abbreviations: CI, confidence interval; NA, not available; OS, overall survival; TTP, time to progression.